Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids

Abstract Coronavirus (CoV) envelope (E) protein ion channel activity was determined in channels formed in planar lipid bilayers by peptides representing either the transmembrane domain of severe acute respiratory syndrome CoV (SARS-CoV) E protein, or the full-length E protein. Both of them formed a...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 432; no. 2; pp. 485 - 494
Main Authors Verdiá-Báguena, Carmina, Nieto-Torres, Jose L, Alcaraz, Antonio, DeDiego, Marta L, Torres, Jaume, Aguilella, Vicente M, Enjuanes, Luis
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 25.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Coronavirus (CoV) envelope (E) protein ion channel activity was determined in channels formed in planar lipid bilayers by peptides representing either the transmembrane domain of severe acute respiratory syndrome CoV (SARS-CoV) E protein, or the full-length E protein. Both of them formed a voltage independent ion conductive pore with symmetric ion transport properties. Mutations N15A and V25F located in the transmembrane domain prevented the ion conductivity. E protein derived channels showed no cation preference in non-charged lipid membranes, whereas they behaved as pores with mild cation selectivity in negatively-charged lipid membranes. The ion conductance was also controlled by the lipid composition of the membrane. Lipid charge also regulated the selectivity of a HCoV-229E E protein derived peptide. These results suggested that the lipids are functionally involved in E protein ion channel activity, forming a protein–lipid pore, a novel concept for CoV E protein ion channel entity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Both authors equally contributed to this work.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2012.07.005